Microglia in animal models of autism spectrum disorders

被引:9
|
作者
Andoh, Megumi [1 ]
Ikegaya, Yuji [1 ]
Koyama, Ryuta [1 ]
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, Tokyo, Japan
来源
AUTISM | 2020年 / 173卷
关键词
MATERNAL IMMUNE ACTIVATION; WILD-TYPE MICROGLIA; MOUSE MODEL; SOCIAL-INTERACTION; BRAIN-DEVELOPMENT; VALPROIC ACID; BEHAVIOR; MICE; RATS; STRESS;
D O I
10.1016/bs.pmbts.2020.04.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Various genetic and environmental factors have been suggested to cause autism spectrum disorders (ASDs). A variety of animal models of ASDs have been developed and used to investigate the mechanisms underlying the pathogenesis of ASDs. These animal models have contributed to clarifying that abnormalities in neuronal morphology and neurotransmission are responsible for the onset of ASDs. In recent years, researchers have started to focus not only on neurons but also on glial cells, particularly microglia. This is because microglial malfunction is strongly associated with structural and functional abnormalities of neurons, as well as the inflammation that is commonly observed both in the brains of patients with ASDs and in animal models of ASDs. In this chapter, we first introduce a list of commonly available animal models of ASDs and describe the validity of each model from the viewpoint of behaviors and neuroanatomy. We next detail the malfunction of microglia that has been reported in animal models of ASDs and discuss the roles of microglia in ASD pathogenesis. We will further propose possible therapeutic strategies to tackle ASDs by controlling microglial functions.
引用
收藏
页码:239 / 273
页数:35
相关论文
共 50 条
  • [41] The glial perspective of autism spectrum disorders
    Zeidan-Chulia, Fares
    Salmina, Alla B.
    Malinovskaya, Natalia A.
    Noda, Mami
    Verkhratsky, Alexei
    Fonseca Moreira, Jose Claudio
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2014, 38 : 160 - 172
  • [42] High expression of Endogenous Retroviruses from intrauterine life to adulthood in two mouse models of Autism Spectrum Disorders
    Cipriani, Chiara
    Ricceri, Laura
    Matteucci, Claudia
    De Felice, Alessia
    Tartaglione, Anna Maria
    Argaw-Denboba, Ayele
    Pica, Francesca
    Grelli, Sandro
    Calamandrei, Gemma
    Vallebona, Paola Sinibaldi
    Balestrieri, Emanuela
    SCIENTIFIC REPORTS, 2018, 8
  • [43] DISORDERS OF MOTOR ACTIVITY ON THE MODEL OF AUTISM SPECTRUM DISORDERS
    Khairullin, A. E.
    Efimova, D. V.
    Ivanova, D. V.
    Baltina, T. V.
    Baltin, M. E.
    Grishin, S. N.
    Ziganshin, A. U.
    ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA, 2023, 73 (06) : 819 - 832
  • [44] The role of neuroglia in autism spectrum disorders
    Scuderi, Caterina
    Verkhratsky, Alexei
    AUTISM, 2020, 173 : 301 - 330
  • [45] Pharmacotherapeutic Effects of Cannabidiol in Mouse Models of Autism Spectrum Disorders
    Parkhill, Michael
    Matende, Adina
    Rodrigue, Brandon
    Lewis, Vern
    Valles, Argel Aguilar
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 165 - 166
  • [46] Therapeutic approaches in autism spectrum disorders
    Ruggieri, Vctor L.
    Arberas, Claudia L.
    REVISTA DE NEUROLOGIA, 2015, 60 : S45 - S49
  • [47] Autism spectrum disorders
    Poustka, Luise
    MONATSSCHRIFT KINDERHEILKUNDE, 2023, 171 (3) : 231 - 238
  • [48] Modeling Inflammation in Autism Spectrum Disorders Using Stem Cells
    Freitas, Beatriz C.
    Mei, Arianna
    Mendes, Ana Paula D.
    Beltrao-Braga, Patricia C. B.
    Marchetto, Maria Carolina
    FRONTIERS IN PEDIATRICS, 2018, 6
  • [49] Probiotics in autism spectrum disorder: Recent insights from animal models
    Golbaghi, Navid
    Naeimi, Saeideh
    Darvishi, Afra
    Najari, Niloofar
    Cussotto, Sofia
    AUTISM, 2024, 28 (11) : 2722 - 2737
  • [50] THE SEROTONIN SYSTEM IN AUTISM SPECTRUM DISORDER: FROM BIOMARKER TO ANIMAL MODELS
    Muller, C. L.
    Anacker, J.
    Veenstra-Vanderweele, J.
    NEUROSCIENCE, 2016, 321 : 24 - 41